Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Abacavir/Lamivudine/Zidovudine"'
Autor:
Pom Mulder, Herman G. Sprenger, R. Vriesendorp, R. W. ten Kate, Clemens Richter, van der Tjipke Werf, Paul H. P. Groeneveld, Bert Bravenboer, A. I. M. Hoepelman, Wouter F W Bierman, Peter P. Koopmans, C. H. H. ten Napel, J. C. Legrand, Nienke Langebeek, E. H. Gisolf
Publikováno v:
HIV Medicine. 16:122-131
ObjectivesThe aim of the study was to test the antiviral efficacy of a triple nucleoside reverse transcriptase inhibitor (NRTI) regimen, with potential beneficial metabolic effects, as maintenance therapy after induction with dual NRTIs and a boosted
Autor:
Enos Bernasconi, Hansjakob Furrer, Milos Opravil, Sabine Yerly, Rainer Weber, Marek Fischer, Huldrych F. Günthard, Bernard Hirschel, Leslie R. Bisset, Colin Howe, Manuel Battegay, Jean Philippe Chave, Pietro Vernazza, Bruno Ledergerber, Adriano Lazzarin, Luc Perrin
Publikováno v:
Opravil, Milos; Hirschel, Bernard; Lazzarin, Adriano; Furrer, Hansjakob; Chave, Jean-Philippe; Yerly, Sabine; Bisset, Leslie R.; Fischer, Marek; Vernazza, Pietro; Bernasconi, Enos; Battegay, Manuel; Ledergerber, Bruno; Günthard, Huldrych; Howe, Colin; Weber, Rainer; Perrin, Luc (2002). A Randomized Trial of Simplified Maintenance Therapy with Abacavir, Lamivudine, and Zidovudine in Human Immunodeficiency Virus Infection. Journal of infectious diseases, 185(9), pp. 1251-1260. The University of Chicago Press 10.1086/340312
The Journal of Infectious Diseases, Vol. 185, No 9 (2002) pp. 1251-1260
The Journal of Infectious Diseases, Vol. 185, No 9 (2002) pp. 1251-1260
This randomized study evaluated the efficacy and tolerability of continued treatment with protease inhibitor plus nucleoside-analogue combination regimens (n = 79) or a change to the simplified regimen of abacavir-lamivudine-zidovudine (n = 84) in pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79ae535520469334e4699c267e1912b4
http://doc.rero.ch/record/303577/files/185-9-1251.pdf
http://doc.rero.ch/record/303577/files/185-9-1251.pdf
Publikováno v:
HIV Medicine. 15(5):286-290
ObjectivesThe aim of the study was to investigate the effect of a simplified regimen, in terms of reducing pill burden, dietary requirements and possible adverse effects, on patients' adherence, treatment satisfaction and quality of life (QoL).Method
Publikováno v:
Antiviral therapy. 19(7):625-636
Background: Single-drug class regimens with nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) are generally not recommended as initial therapy because they are inferior compared with therapy with two NRTIs plus efavirenz. However, triple
Autor:
Peter Reiss, Pythia T. Nieuwkerk, Clemens Richter, M. A. G. Sprangers, Herman G. Sprenger, E. H. Gisolf, Nienke Langebeek, J. C. Legrand
Publikováno v:
HIV Medicine. 15:286-290
Objectives The aim of the study was to investigate the effect of a simplified regimen, in terms of reducing pill burden, dietary requirements and possible adverse effects, on patients' adherence, treatment satisfaction and quality of life (QoL). Meth
Autor:
Wouter F W Bierman, Clemens Richter, Tjip S. van der Werf, Elisabeth H. Gisolf, Herman G. Sprenger
Publikováno v:
Antiviral Therapy. 19:625-636
Background Single-drug class regimens with nucleoside/ nucleotide reverse transcriptase inhibitors (NRTIs) are generally not recommended as initial therapy because they are inferior compared with therapy with two NRTIs plus efavirenz. However, triple
Autor:
Elie Mulhem
Publikováno v:
Cochrane Clinical Answers
Autor:
Katrina L. Oie, John E. Fuchs, Dean T. Martin, Gary E. Pakes, Benjamin Daquioag, Joseph C. Gathe, Vanessa C. Williams, M. Keith Rawlings
Publikováno v:
World Journal of AIDS. :245-251
Objective: The purpose of this study was to investigate whether switching HIV-infected patients stabilized on Trizivir (abacavir 300 mg/lamivudine 150 mg/zidovudine 300 mg) plus lopinavir/ritonavir 400 mg/100mg twice daily to Trizivir alone affects c
Autor:
Belinda Ha, David Irlbeck, Edwin DeJesus, Vanessa C. Williams, Charles T Lancaster, Allan Rodriguez, Lisa L. Ross
Publikováno v:
The Open AIDS Journal
In HBV/HIV-coinfected patients, the risk of end-stage liver disease and death is increased. This open-label, prospective, pilot study evaluated abacavir/lamivudine/zidovudine twice daily plus tenofovir once daily in HBV/HIV- coinfected antiretroviral
Autor:
Joseph Horton, Belinda Ha, Lisa L. Ross, Richard Elion, E. R. Lanier, C. Cohen, Peter Gerondelis, E. Rouse, Edwin DeJesus
Publikováno v:
Journal of Antimicrobial Chemotherapy
Background HIV clonal genotypic analysis (CG) was used to investigate whether a more sensitive analysis method would detect additional low-abundance mutations compared with population genotyping (PG) in antiretroviral-naive patients who experienced v